National Research (NRCIA) Rating Increased to Buy at BidaskClub

National Research (NASDAQ:NRCIA) was upgraded by BidaskClub from a “hold” rating to a “buy” rating in a report released on Friday.

Separately, Zacks Investment Research downgraded National Research from a “hold” rating to a “strong sell” rating in a report on Friday, November 10th.

Shares of National Research (NASDAQ NRCIA) traded down $0.30 during mid-day trading on Friday, hitting $38.15. The company’s stock had a trading volume of 12,320 shares, compared to its average volume of 27,251. The firm has a market cap of $993.60, a P/E ratio of 43.35 and a beta of 1.56. National Research has a 52-week low of $16.50 and a 52-week high of $41.99.

National Research (NASDAQ:NRCIA) last issued its earnings results on Tuesday, November 7th. The business services provider reported $0.09 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.21 by ($0.12). National Research had a net margin of 19.09% and a return on equity of 30.84%. equities analysts expect that National Research will post 0.88 earnings per share for the current fiscal year.

In related news, major shareholder K/I/E/Trust Under Agreement 3/ sold 9,000 shares of the firm’s stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of $36.50, for a total transaction of $328,500.00. Following the sale, the insider now owns 5,626,167 shares of the company’s stock, valued at approximately $205,355,095.50. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 37.54% of the company’s stock.

A number of institutional investors and hedge funds have recently made changes to their positions in NRCIA. Schwab Charles Investment Management Inc. lifted its holdings in National Research by 0.6% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 30,453 shares of the business services provider’s stock worth $820,000 after buying an additional 190 shares during the period. Alliancebernstein L.P. lifted its holdings in National Research by 5.1% during the 2nd quarter. Alliancebernstein L.P. now owns 12,369 shares of the business services provider’s stock worth $333,000 after buying an additional 600 shares during the period. Teachers Advisors LLC lifted its holdings in National Research by 36.6% during the 2nd quarter. Teachers Advisors LLC now owns 17,691 shares of the business services provider’s stock worth $476,000 after buying an additional 4,736 shares during the period. Citigroup Inc. lifted its holdings in National Research by 120.2% during the 2nd quarter. Citigroup Inc. now owns 8,299 shares of the business services provider’s stock worth $224,000 after buying an additional 4,531 shares during the period. Finally, Northern Trust Corp lifted its holdings in National Research by 11.5% during the 2nd quarter. Northern Trust Corp now owns 144,413 shares of the business services provider’s stock worth $3,884,000 after buying an additional 14,856 shares during the period. 25.05% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: “National Research (NRCIA) Rating Increased to Buy at BidaskClub” was published by American Banking News and is the property of of American Banking News. If you are accessing this report on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this report can be accessed at https://www.americanbankingnews.com/2018/01/27/national-research-nrcia-rating-increased-to-buy-at-bidaskclub.html.

About National Research

National Research Corporation, doing business as NRC Health, is a provider of analytics and insights for healthcare providers, payers and other healthcare organizations. The Company operates through six segments: Experience, The Governance Institute, Market Insights, Transparency, National Research Corporation Canada and Connect.

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply